BC
GNMK

Brookfield Corp’s GenMark Diagnostics, Inc GNMK Stock Holding History

Brookfield Corp’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-183,801
Closed -$4.39M – 697
2021
Q1 		$4.39M Buy
+183,801
New +$3.42M 0.02% 182

Brookfield Corp's GNMK Position: Q2 2021 in Review

Brookfield Corp sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 183,801 shares — an estimated $4.39M sold.

Brookfield Corp first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $4.39M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Brookfield Corp reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Brookfield Corp sold 183,801 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4.39M.
  • Brookfield Corp first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Brookfield Corp's GenMark Diagnostics, Inc position peaked at $4.39M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Brookfield Corp's 13F filing for Q2 2021, filed 17 Aug 2021.